Home › Funds › Two Sigma Investments › SNSE
Two Sigma Investments position in SNSE
FAETH THERAPEUTICS INC
Latest position (Q1 2024)10.18K sh
Reported value held$10.69K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 28.77K | $167.00K | New |
| Q1 2022 | 62.18K | $144.00K | Add |
| Q2 2022 | 38.78K | $88.00K | Reduce |
| Q3 2022 | 35.78K | $55.00K | Reduce |
| Q4 2022 | 31.08K | $46.30K | Reduce |
| Q1 2023 | 15.28K | $22.91K | Reduce |
| Q2 2023 | 13.58K | $15.48K | Reduce |
| Q3 2023 | 10.88K | $8.70K | Reduce |
| Q4 2023 | 10.18K | $7.04K | Reduce |
| Q1 2024 | 10.18K | $10.69K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SNSE
- Balyasny Asset Management 1.04M sh · $26.05M · Q2 2026
- Franklin Resources 494.52K sh · $12.36M · Q2 2026
- Marshall Wace 206.51K sh · $5.16M · Q2 2026
- Morgan Stanley 17.33K sh · $433.23K · Q2 2026
- Geode Capital Management 14.62K sh · $365.44K · Q2 2026
- BlackRock Inc 3.40K sh · $85.05K · Q2 2026
- JPMorgan Chase & Co 40 sh · $929 · Q2 2026